Chronische Schmerzen – Placebo- und Noceboeffekte kennen und nutzen

Die Wirksamkeit eines Medikaments kann durch das Gespräch mit dem Patienten verstärkt werden – aber auch seine Nebenwirkungen. Doch wie können Ärzte dieses Wissen nutzen, um den Behandlungserfolg zu verbessern? Dieser Beitrag erläutert die wesentlichen Grundlagen des Placebo- und Noceboprinzips bei Schmerzpatienten.

• Literatur

• 1 Benedetti F, Amanzio M, Vighetti S et al. The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J Neurosci 2006; 26: 12014-12022
• 2 Benedetti F, Amanzio M, Rosato R et al. Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nat Med 2011; 17: 1228-1230
• 3 Bingel U, Lorenz J, Schoell E et al. Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain 2006; 120: 8-15
• 4 Bingel U, Wanigasekera V, Wiech K et al. The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med 2011; 3: 70ra14
• 5 Bingel U. Avoiding Nocebo Effects to Optimize Treatment Outcome. JAMA 2014; 312: 693-694
• 6 Colloca L, Benedetti F. How prior experience shapes placebo analgesia. Pain 2006; 124: 126-133
• 7 Colloca L, Benedetti F. Placebo analgesia induced by social observational learning. Pain 2009; 144: 28-34
• 8 Colloca L, Lopiano L, Lanotte M et al. Overt versus covert treatment for pain, anxiety, and Parkinson’s disease. Lancet Neurol 2004; 3: 679-684
• 9 Colloca L, Klinger R, Flor H et al. Placebo analgesia: psychological and neurobiological mechanisms. Pain 2013; 154: 511-514
• 10 Eippert F, Bingel U, Schoell ED et al. Activation of the Opioidergic Descending Pain Control System Underlies Placebo Analgesia. Neuron 2009; 63: 533-543
• 11 Eippert F, Finsterbusch J, Bingel U et al. Direct evidence for spinal cord involvement in placebo analgesia. Science 2009; 326: 404
• 12 Enck P, Benedetti F, Schedlowski M. New Insights into the Placebo and Nocebo Responses. Neuron 2008; 59: 195-206
• 13 Finniss DG, Kaptchuk TJ, Miller F et al. Biological, clinical, and ethical advances of placebo effects. Lancet 2010; 375: 686-695
• 14 Kessner S, Wiech K, Forkmann K et al. The effect of treatment history on therapeutic outcome: an experimental approach. JAMA Intern Med 2013; 173: 1468-1469
• 15 Klinger R. Das Potiential des analgetischen Placeboeffektes: S3-Leitlinien-Empfehlung des Klinischen Nutzens für die Schmerztherapie. Anasthesiol Intensivmed Notfallmed Schmerzther 2010; 45: 22-29
• 16 Klinger R, Colloca L, Bingel U et al. Placebo analgesia: Clinical applications. Pain 2014; 155: 1055-1058
• 17 Klinger R, Flor H. Clinical and ethical implications of placebo effects: enhancing patients’ benefits from pain treatment. Handb Exp Pharmacol 2014; 225: 217-235
• 18 Klinger R, Soost S, Flor H et al. Classical conditioning and expectancy in placebo hypoalgesia: a randomized controlled study in patients with atopic dermatitis and persons with healthy skin. Pain 2007; 128: 31-39
• 19 Petrovic P, Kalso E, Petersson KM et al. Placebo and opioid analgesia – imaging a shared neuronal network. Science 2002; 295: 1737-1740
• 20 Price DD, Finniss DG, Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol 2008; 59: 565-590
• 21 Swider K, Babel P. The effect of the sex of a model on nocebo hyperalgesia induced by social observational learning. Pain 2013; 154: 1312-1317
• 22 Wager TD, Rilling JK, Smith EE et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 2004; 303: 1162-1167